Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases.
暂无分享,去创建一个
Aiming Sun | Yoichi Shinkai | James P Snyder | Mark T Bedford | J. Snyder | Xiaodong Cheng | Y. Shinkai | Xing Zhang | J. Horton | M. Bedford | Astrid Spannhoff | Aiming Sun | Xiaodong Cheng | Thota Ganesh | John R Horton | Xing Zhang | Yanqi Chang | T. Ganesh | Astrid Spannhoff | Jin Liu | Jin Liu | Yanqi Chang
[1] Cristiano Ruch Werneck Guimarães,et al. MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization , 2008, J. Chem. Inf. Model..
[2] P. Cole,et al. Chemical probes for histone-modifying enzymes. , 2008, Nature chemical biology.
[3] Paul Greengard,et al. Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity , 2010, Science.
[4] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[5] J. Snyder,et al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 , 2009, Nature Structural &Molecular Biology.
[6] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[7] Y Ikawa,et al. A novel ES cell line, TT2, with high germline-differentiating potency. , 1993, Analytical biochemistry.
[8] R. Smits,et al. Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. , 2008, Journal of medicinal chemistry.
[9] Paul D Lyne,et al. Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.
[10] D. Reinberg,et al. Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins*S⃞ , 2009, Journal of Biological Chemistry.
[11] Robert A. Copeland,et al. Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.
[12] D. Langley,et al. O-Debenzylation of a Pyrrolo[2,1-c][1,4]benzodiazepine in the Presence of a Carbinolamine Functionality: Synthesis of DC-81 , 1990 .
[13] C. Song,et al. A modified synthesis of iodoazidoaryl prazosin. , 2002, The Journal of organic chemistry.
[14] Anton Simeonov,et al. Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. , 2009, Journal of medicinal chemistry.
[15] M. Hsu,et al. An efficient synthesis of pyrrolo[2,1-c][1,4]benzodiazepine. Synthesis of the antibiotic DC-81. , 2001, The Journal of organic chemistry.
[16] Sascha Karberg. Switching on Epigenetic Therapy , 2009, Cell.
[17] Karl Mechtler,et al. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. , 2007, Molecular cell.
[18] Valérie Campagna-Slater,et al. Structural Biology of Human H3K9 Methyltransferases , 2010, PloS one.